ID

31132

Descripción

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00700180

Link

https://clinicaltrials.gov/show/NCT00700180

Palabras clave

Versiones (1)
  1. 21/7/18 21/7/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

21 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Small Cell Lung Cancer NCT00700180

Inglés

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Descripción

Adult | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
Descripción

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4288755
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2,1]
C4288304
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
>=1 measurable tumor lesion;
Descripción

Measurable lesion Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
ecog performance status 0-1.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy or treatment with another systemic anti-cancer agent;
Descripción

Prior Chemotherapy | Antineoplastic Agents Systemic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0003392
UMLS CUI [2,2]
C0205373
evidence of cns metastases;
Descripción

CNS metastases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0686377
history of grade 2 or higher hemoptysis;
Descripción

Hemoptysis CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019079
UMLS CUI [1,2]
C1516728
evidence of tumor invading or abutting major blood vessels;
Descripción

Tumor Invasion Blood Vessel Major

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1269955
UMLS CUI [1,2]
C0005847
UMLS CUI [1,3]
C0205164
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
Descripción

Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007131
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0553723
UMLS CUI [5,3]
C1522326
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0600139
UMLS CUI [6,3]
C0392752
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0007124
clinically significant cardiovascular disease;
Descripción

Cardiovascular Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
Descripción

Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003280
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0443225
UMLS CUI [3]
C0016018
Volver a la parte superior de la página

Similar models

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally
Item
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
boolean
C4288755 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C4288304 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
Measurable lesion Quantity
Item
>=1 measurable tumor lesion;
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | Antineoplastic Agents Systemic
Item
prior chemotherapy or treatment with another systemic anti-cancer agent;
boolean
C1514457 (UMLS CUI [1])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
CNS metastases
Item
evidence of cns metastases;
boolean
C0686377 (UMLS CUI [1])
Hemoptysis CTCAE Grades
Item
history of grade 2 or higher hemoptysis;
boolean
C0019079 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Tumor Invasion Blood Vessel Major
Item
evidence of tumor invading or abutting major blood vessels;
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS
Item
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0600139 (UMLS CUI [6,2])
C0392752 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0007124 (UMLS CUI [7,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease;
boolean
C0007222 (UMLS CUI [1])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial